Ketkar M, Desai S, Rana P, Thorat R, Epari S, Dutt A, Dutt S. (2024). Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro Oncol. 2024 Jul 18:noae134.  doi: 10.1093/neuonc/noae134. [READ]

Noronha, V., Budukh, A., Chaturvedi, P., Anne, S., Punjabi, A., Bhaskar, M., ... Dutt A, & Prabhash, K. (2024). Uniqueness of lung cancer in Southeast Asia. The Lancet Regional Health-Southeast Asia. [READ]

​

Prabhash, K., Saldanha, E., Patil, V., Bal, M., Reddy P, S., Sanjeev, A., ... Dutt A, & Chandrani, P. (2024). RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer. 𝘑𝘊𝘖 𝘗𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺, 8, e2300622. [READ]

​​

Dharavath B, Butle A, Chaudhary A, Pal A, Desai S, Chowdhury A, Thorat R, Upadhyay P, Nair S, Dutt A. Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications. 𝘯𝘱𝘫 𝘗𝘳𝘦𝘤𝘪𝘴. 𝘖𝘯𝘤. 8, 63 (2024). [READ]

​

Desai, S., Ahmad, S., Bawaskar, B., Rashmi, S., Mishra, R., Lakhwani, D. and Dutt, A., 2024. Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. 𝘕𝘈𝘙 𝘤𝘢𝘯𝘤𝘦𝘳, 6(1), p.zcae010. https://doi.org/10.1093/narcan/zcae010  [READ]

​

Rekhi, B., Dave, V., Butle, A., Dharavath, B., Khetale, S., Redhu, A. K., ... & Dutt, A. (2024). Immunohistochemical expression of H3. 3 G34W in 100 giant cell tumors of bone and its diagnostic mimics, including its value in resolving uncommon diagnostic scenarios: A single institutional study at a tertiary cancer referral center, India. 𝘐𝘯𝘥𝘪𝘢𝘯 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘗𝘢𝘵𝘩𝘰𝘭𝘰𝘨𝘺 𝘢𝘯𝘥 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘭𝘰𝘨𝘺, 10-4103. [READ]

​

Chaubal R, Gardi N, Joshi S, Pantvaidya G, Kadam R, Vanmali V, Hawaldar R, Talker E, Chitra J, Gera P, Bhatia D, Kalkar P, Gurav M, Shetty O, Desai S, Krishnan NM, Nair N, Parmar V, Dutt A, Panda B, Gupta S, Badwe R. 2024. Surgical tumour resection deregulates Hallmarks of Cancer in resected tissue and the surrounding microenvironment. 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩. [READ]

​

Gaur, T., Ali, A., Sharma, D., Gupta, S. K., Gota, V., Bagal, B., ... & Hasan, S. K. (2024). Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. 𝘊𝘦𝘭𝘭𝘶𝘭𝘢𝘳 𝘚𝘪𝘨𝘯𝘢𝘭𝘭𝘪𝘯𝘨, 114, 111004. [READ]

Gaur, T., Ali, A., Sharma, D., Gupta, S.K., Gota, V., Bagal, B., Platzbeckar, U., Mishra, R., Dutt, A., Khattry, N. and Mills, K., 2024. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. 𝘊𝘦𝘭𝘭𝘶𝘭𝘢𝘳 𝘚𝘪𝘨𝘯𝘢𝘭𝘭𝘪𝘯𝘨, 114, p.111004. https://doi.org/10.1016/j.cellsig.2023.111004  [READ]

​

Trivedi, V., Noronha, V., Sreekanthreddy, P., Desai, S., Poojary, D., Varghese, L., Gowda, P., Butle, A., Mishra, R., Bal, M. and Mittal, N., 2023. Association of Cutibacterium acnes with human thyroid cancer. 𝘍𝘳𝘰𝘯𝘵𝘪𝘦𝘳𝘴 𝘪𝘯 𝘌𝘯𝘥𝘰𝘤𝘳𝘪𝘯𝘰𝘭𝘰𝘨𝘺, 14, p.1152514. https://doi.org/10.3389/fendo.2023.1152514 [READ]

​

Kaur, J., Singh, A., Shah, M., Chandrani, P., Chougule, A., Shetty, O., Pai, T., Menon, S., Yadav, S., Kapoor, A. and Mishra, B.K., 2023. Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩, 𝘚𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘴, 𝘢𝘯𝘥 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵, 6(2), pp.288-295. DOI: 10.4103/crst.crst_176_23 [READ]

​

Chougule, A., Chandrani, P., Noronha, V., Pange, P., Kale, S., Nikam, A., Nambiar, K., Marchande, D., Durve, A., Gupta, V. and Jagtap, V., 2023. Real-World Evidence of EGFR Targeted Therapy in NSCLC–A Brief Report of Decade Long Single Center Experience. 𝘑𝘛𝘖 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘙𝘦𝘱𝘰𝘳𝘵𝘴, 4(11), p.100566. https://doi.org/10.1016/j.jtocrr.2023.100566 [READ]

​

Gaur, T., Poddutoori, R., Khare, L., Bagal, B., Rashmi, S., Patkar, N., Tembhare, P., Pg, S., Shetty, D., Dutt, A. and Zhang, Q., 2023. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘌𝘹𝘱𝘦𝘳𝘪𝘮𝘦𝘯𝘵𝘢𝘭 & 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩, 42(1), p.186. ​https://doi.org/10.1186/s13046-023-02750-w [READ]

​

Chakravorty, G., Ahmad, S., Godbole, M.S., Gupta, S., Badwe, R.A. and Dutt, A., 2023. Deciphering the mechanisms of action of progesterone in breast cancer. 𝘖𝘯𝘤𝘰𝘵𝘢𝘳𝘨𝘦𝘵, 14, p.660. doi: 10.18632/oncotarget.28455 [READ]

​

Rekhi, B., Dave, V., Butle, A. and Dutt, A., 2023. Utility of immunohistochemical expression of H3. 3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center. 𝘈𝘯𝘯𝘢𝘭𝘴 𝘰𝘧 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤 𝘗𝘢𝘵𝘩𝘰𝘭𝘰𝘨𝘺, 66, p.152174.  https://doi.org/10.1016/j.anndiagpath.2023.152174 [READ] 

​

Butti, R., Kapse, P., Bhadauriya, G., Ahmad, S., Chaubal, R., Parab, P., Kadam, R., Mahapatra, S.S., Shet, T., Dutt, A. and Gupta, S., 2023. Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer. 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 𝘙𝘦𝘱𝘰𝘳𝘵𝘴, 49(5), pp.1-10. https://doi.org/10.3892/or.2023.8536  [READ]

​

Dharavath, B., Butle, A., Pal, A., Desai, S., Upadhyay, P., Rane, A., Khandelwal, R., Manavalan, S., Thorat, R., Sonawane, K. and Vaish, R., 2023. Role of miR-944/MMP10/AXL-axis in lymph node metastasis in tongue cancer. 𝘊𝘰𝘮𝘮𝘶𝘯𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘣𝘪𝘰𝘭𝘰𝘨𝘺, 6(1), p.57. https://doi.org/10.1038/s42003-023-04437-6   [READ] [SUMMARY]

​

​Joshi, A., Dharavath, B., Chowdhary, A., Singh, R., Desai, S. and Dutt, A., 2023. Genetic Alterations and Microbial Dysbiosis Underlie Lymph Node Metastasis in Tongue Cancer.  [READ]

​

Desai S, Dharavath B, Manavalan S, Rane A, Redhu AK, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam MD, Banerjee A, Prabhash K, Nair S,Dutt A. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. 𝘕𝘈𝘙 𝘊𝘢𝘯𝘤𝘦𝘳 2022 Mar 4;4(1):zcac006. doi: 10.1093/narcan/zcac006. eCollection 2022 Mar. PMID: 35252868, PMCID: PMC8894079
[READ]
 
Desai S, Mishra R, Ahmad S, Hait S, Joshi A, Dutt A. TMC-SNPdb 2.0: an ethnic-specific database of Indian germline variants. 𝘋𝘢𝘵𝘢𝘣𝘢𝘴𝘦 (𝘖𝘹𝘧𝘰𝘳𝘥) 2022, May 11;2022. pii: baac029. doi: 10.1093/database/baac029. PMID:35551364, PMCID: PMC9216475
[READ]
 
Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K Dutt A. Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. 𝘛𝘳𝘢𝘯𝘴𝘭 𝘖𝘯𝘤𝘰𝘭. 2022 Aug;22:101461. doi: 10.1016/j.tranon.2022.101461. Epub 2022 May 30. PMID: 35653897, PMCID: PMC9156817
[READ]
 
Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M Dutt A. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴. 2022, Dec 28;24(1):97. doi: 10.1186/s13058-022-01597-x. PMID: 36578092, PMCID: PMC9798554
[READ]
 
 

Desai S, Rashmi S, Rane A, Dharavath B, Sawant A, Dutt A. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome. 𝘉𝘳𝘪𝘦𝘧 𝘉𝘪𝘰𝘪𝘯𝘧𝘰𝘳𝘮. 2021 Mar 22;22(2):1065-1075. doi: 10.1093/bib/bbaa437. PMID: 33479725, PMCID: PMC7929363
[READ]
 

Joshi A, Mishra R, Desai S, Chandrani P, Kore H, Sunder R, Hait S, Iyer P, Trivedi V, Choughule A, Noronha V, Joshi A, Patil V, Menon N, Kumar R, Prabhash K, Dutt A. Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. 𝘖𝘯𝘤𝘰𝘵𝘢𝘳𝘨𝘦𝘵. 2021 Mar 16;12(6):578-588. doi: 10.18632/oncotarget.27905. eCollection 2021 Mar 16. PMID: 33796225, PMCID: PMC7984830
[READ]
 
Desai S, Rane A, Joshi A,Dutt A. IPD 2.0: To derive insights from an evolving SARS-CoV-2 genome. 𝘉𝘔𝘊 𝘉𝘪𝘰𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘤𝘴. 2021 May 13;22(1):247. doi:10.1186/s12859-021-04172-x. PMID: 33985433, PMCID: PMC8118100
[READ]
 
Butle A, Joshi A, Noronha V, Prabhash K,Dutt A. Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs. 𝘛𝘳𝘢𝘯𝘴𝘭 𝘖𝘯𝘤𝘰𝘭. 2021 Aug;14(8):101111. doi: 10.1016/j.tranon.2021.101111. Epub 2021 May 13. PMID: 33993094, PMCID: PMC8236545
[READ]
 
Desai S, Mishra R, Ahmad S, Hait S, Joshi A, Dutt A. TMC-SNPdb 2.0: an ethnic-specific database of Indian germline variants. 𝘋𝘢𝘵𝘢𝘣𝘢𝘴𝘦 (𝘖𝘹𝘧𝘰𝘳𝘥) 2022, May 11;2022. pii: baac029. doi: 10.1093/database/baac029. PMID:35551364, PMCID: PMC9216475
[READ] [SUMMARY]
 
Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K Dutt A. Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. 𝘛𝘳𝘢𝘯𝘴𝘭 𝘖𝘯𝘤𝘰𝘭. 2022 Aug;22:101461. doi: 10.1016/j.tranon.2022.101461. Epub 2022 May 30. PMID: 35653897, PMCID: PMC9156817
[READ] [SUMMARY]
 
Yadav N, Sunder R, Desai S, Dharavath B, Chandrani P, Godbole M, Dutt A. Progesterone modulates the DSCAM-AS1/miR-130a/ESR1 axis to suppress cell invasion and migration in breast cancer. 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴. 2022, Dec 28;24(1):97. doi: 10.1186/s13058-022-01597-x. PMID: 36578092, PMCID: PMC9798554
[READ] [SUMMARY]
 
Noronha V, Chougule A, Chandrani P, Kaushal RK, Patil VM, Menon N, Kapoor A, Chopade S, Singh A, Shetty O, Banavali S, Prabhash K. Dutt A. Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study. 𝘈𝘤𝘵𝘢 𝘖𝘯𝘤𝘰𝘭. 2022, Sep;61(9):1143-1147. doi: 10.1080/0284186X.2022.2109426. Epub 2022 Aug 16. PMID: 35972844
[READ]
 
Rekhi B, Dodd L, Dharavath B, Dutt A. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result. 𝘋𝘪𝘢𝘨𝘯 𝘊𝘺𝘵𝘰𝘱𝘢𝘵𝘩𝘰𝘭. 2022, Dec;50(12):E367-E372. doi: 10.1002/dc.25032. Epub 2022 Aug 5. PMID: 35929754
[READ]
 
Behel V, Noronha V, Choughule A, Shetty O, Chandrani P, Kapoor A, Bondili SK, Bajpai J, Kumar R, Pai T, Bal M, Gurav M, Bapat P, Mittal N, Menon S, Patil V, Menon N, Prabhash KDutt A. Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer. 𝘑𝘊𝘖 𝘎𝘭𝘰𝘣 𝘖𝘯𝘤𝘰𝘭. 2022, Jul;8:e2200030. doi: 10.1200/GO.22.00030.PMID: 35802838 PMCID: PMC9296182
[READ]
 

Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K.,Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer. 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺. 2020 Jan 10;38(2):124-136.
[READ]

Kaur E, Nair J, Ghorai A, Mishra SV, Achareker A, Ketkar M, Sarkar D, Salunkhe S, Rajendra J, Gardi N, Desai S, Iyer P, Thorat R, Moiyadi A, Dutt S.Dutt A. Inhibition of SETMAR-H3K36me2-NHEJ repair axis in residual disease cells prevents glioblastoma recurrence 𝘕𝘦𝘶𝘳𝘰 𝘖𝘯𝘤𝘰𝘭. 2020 Dec 18;22(12):1785-1796. doi: 10.1093/neuonc/noaa128. PMID: 32458986 PMCID: PMC7746947
[READ]
 
Togar T, Desai S, Mishra R, Terwadkar P, Ramteke M, Ranjan M, Kawle D, Sahoo B, Pal A, Upadhyay P,Dutt A. , Identifying cancer driver genes from functional genomics screens 𝘚𝘸𝘪𝘴𝘴 𝘔𝘦𝘥 𝘞𝘬𝘭𝘺 2020. 2021 Feb.10.4414/smw.2020.20195. eCollection 2020 Feb 10. PMID: 32083704
[READ] [SUMMARY]
 
Desai S, Mishra SV, Joshi A, Sarkar D, Hole A, Mishra R, Dutt S, Chilakapati MK, Gupta S,Dutt A. Raman spectroscopy-based detection of RNA viruses in saliva: A preliminary report 𝘑 𝘉𝘪𝘰𝘱𝘩𝘰𝘵𝘰𝘯𝘪𝘤𝘴. 2020 Oct;13(10):e202000189, doi:10.1002/jbio.202000189. Epub 2020 Aug 10. PMID: 32609429, PMCID: PMC7361326
[READ] [SUMMARY]
 
Dharavath B, Yadav N, Desai S, Sunder R, Mishra R, Ketkar M, Bhanshe P, Gupta A, Redhu AK, Patkar N, Dutt S, Gupta S,Dutt A. A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2.Heliyon. 2020 doi: 10.1016/j.𝘩𝘦𝘭𝘪𝘺𝘰𝘯.2020.e04405. eCollection 2020 Jul. PMID: 32665985, PMCID: PMC7341355
[READ] [SUMMARY]
 
Salunkhe S, Mishra SV, Ghorai A, Hole A, Chandrani P, Chilakapati M, Dutt SDutt A. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics 𝘉𝘪𝘰𝘤𝘩𝘪𝘮 𝘉𝘪𝘰𝘱𝘩𝘺𝘴 𝘈𝘤𝘵𝘢 𝘉𝘪𝘰𝘦𝘯𝘦𝘳𝘨. 2020 Dec 1;1861(12):148300. doi: 10.1016/j.bbabio.2020.148300. Epub 2020 Aug 25. PMID: 32858000
[READ]

​

Singh S, Kumar M, Kumar S, Sen S, Upadhyay P, Bhattacharjee S, M N, Tomar VS, Roy S, Dutt A, Kundu TK. ,The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis. 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘤𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺. 2019 Sep 20;294(38):14081-14095.
[READ]

Arora R, Rekhi B, Chandrani P, Krishna S, Dutt A. ,Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘢𝘭 𝘗𝘢𝘵𝘩𝘰𝘨𝘦𝘯𝘦𝘴𝘪𝘴. 2019 Dec;137:103778.
[READ]

Sikder S, Kumari S, Kumar M, Sen S, Singhal NB, Chellappan S, Godbole M, Chandrani P, Dutt A, Gopinath KS, Kundu TK.,Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. 𝘖𝘯𝘤𝘰𝘵𝘢𝘳𝘨𝘦𝘵. 2019 Dec 3;10(64):6855-6869. [READ]

​

Rajendra J, Datta KK, Ud Din Farooqee SB, Thorat R, Kumar K, Gardi N, Kaur E, Nair J, Salunkhe S, Patkar K, Desai S, Goda JS, Moiyadi A, Dutt A, Venkatraman P, Gowda H, Dutt S. Enhanced proteasomal activity is essential for long termsurvival and recurrence of innately radiation resistant residual glioblastoma cells. 𝘖𝘯𝘤𝘰𝘵𝘢𝘳𝘨𝘦𝘵. 2018 Jun 12; 9(45):27667-27681.
[READ]

Chatterjee S, Chaubal R, Maitra A, Gardi N, Dutt A, Gupta S, Badwe RA, Majumder PP, Pandey P. Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress. 𝘉𝘳𝘦𝘢𝘴𝘵 𝘤𝘢𝘯𝘤𝘦𝘳 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵. 2018 Jul;170(2):431-438.
[READ]

Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘫𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘤𝘢𝘯𝘤𝘦𝘳. 2018 Oct 10.
[READ] [SUMMARY].

This work was featured here:
 [natureINDIA][wellcomedbt] [The Hindu]
Salunkhe S, Chandran N, Chandrani P, Dutt A ,Dutt S., CytoPred: 7-gene pair metric for AML cytogenetic risk prediction. Briefings in bioinformatics. 𝘉𝘳𝘪𝘦𝘧𝘪𝘯𝘨𝘴 𝘪𝘯 𝘣𝘪𝘰𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘤𝘴. 2018 Oct 30.
[READ]

Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, Prasad R, Dhamne H, Karve K, Salunkhe S, Kawle D, Chandrani P, Dutt S, Gupta S, Badwe RA, Dutt A. Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and PR-negative breast cancer cells. 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘤𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺. 2018 Dec 14;293(50):19263-19276. NIHMSID: EMS80387
[READ] [SUMMARY]

 This work was featured here:
 [The Hindu]

Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, Tidke P, Pancholi N, Gupta D, Prasannan P, Gaikwad A, Gardi N, Chaubal R, Upadhyay P, Pal K, Rane B, Shaikh A, Salunkhe S, Dutt S, Mishra PK, Khare NK, Nair NK, Dutt A . Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. 𝘊𝘦𝘭𝘭 𝘋𝘦𝘢𝘵𝘩 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺, 2017.3, 17015; doi:10.1038/cddiscovery.2017.15
[READ] [SUMMARY]

Bhat S, Gardi N, Hake S, Kotian N, Sawant S, Kannan S, Parmar V, Desai S, Dutt A, Joshi NN . Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients. 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 . 2017 May 3. doi: 10.1007/s00432-017-2431-5
[READ]

Noronha V, Chougule A, Patil VM, Joshi A, Kumar V, Philip DSJ, Banavasi S, Dutt A, Prabhash K . Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment. 𝘖𝘯𝘤𝘰𝘛𝘢𝘳𝘨𝘦𝘵𝘴 𝘢𝘯𝘥 𝘛𝘩𝘦𝘳𝘢𝘱𝘺 . 2017
[READ]

Upadhyay P, Gardi N, Desai S, Chandrani P, Joshi A, Dharavath B, Arora P, Bal M, Nair S, Dutt A. Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastases. 𝘖𝘳𝘢𝘭 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 73:56-64, 2017
[READ] [SUMMARY]

  This work was featured here:
 [natureINDIA] [IndiaBioscience] [wellcomedbt] [The Hindu]

Godbole M, Tiwary K, Badwe R, Gupta S, Dutt A. Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status. 𝘊𝘦𝘭𝘭𝘶𝘭𝘢𝘳 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺. 2017
[READ] [SUMMARY]

  This work was featured here:
 [wellcomedbt] [The Hindu]

Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A. miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘉𝘪𝘰𝘭𝘰𝘨𝘺 & 𝘛𝘩𝘦𝘳𝘢𝘱𝘺. 2017
[READ] [SUMMARY]
  This work was featured here:
 [wellcomedbt] [The Hindu]

​

Iyer P, Barreto SG, Sahoo B, Chandrani P, Ramadwar MR, Shrikhande SV, Dutt A. Non-typhoidal Salmonella DNA traces in gallbladder cancer. 𝘐𝘯𝘧𝘦𝘤𝘵 𝘈𝘨𝘦𝘯𝘵 𝘊𝘢𝘯𝘤𝘦𝘳. 2016 Mar 3;11:12.
[READ] [SUMMARY]
  This work was featured here:
 [IndiaBioscience][Wellcome Trust DBT]

Barreto SG and Dutt A. To improve outcomes of gallbladder cancer we need to better understand it! 𝘏𝘦𝘱𝘢𝘵𝘰𝘣𝘪𝘭𝘪𝘢𝘳𝘺 𝘚𝘶𝘳𝘨 𝘕𝘶𝘵𝘳 2016;5(4):379-381. doi: 10.21037/hbsn.2016.05.06
[READ]

Kaur E, Sahu A, Hole AR, Rajendra J, Chaubal R, Gardi N, Dutt A., Moiyadi A, Krishna CM, Dutt S. Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population. 𝘚𝘤𝘪 𝘙𝘦𝘱. 2016 May 25;6:26538. doi: 10.1038/srep26538.
[READ] [SUMMARY]

Upadhyay P, Gardi N*, Desai S*, Sahoo B, Singh A,Togar T, Iyer P, Prasad R, Chandrani P, Gupta S, Dutt A. TMC-SNPdb: an Indian germline variant dataset derived from whole exome sequence. 𝘋𝘢𝘵𝘢𝘣𝘢𝘴𝘦, 2016, 1–8. doi: 10.1093/database/baw104
[READ] [SUMMARY]

38. Upadhyay P*, Nair S*, Kaur E, Aich J, Dani P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, Prasad R, Kannan S, Agarwal A, Kane S, Gupta S, Dutt S, Dutt A. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. 𝘖𝘯𝘤𝘰𝘵𝘢𝘳𝘨𝘦𝘵 2016
[READ] [SUMMARY]

Bharat Rekhi*, Pawan Upadhyay*, Manoj P. Ramteke Dutt A. MYOD1 (L122R) Mutations Are Associated with Spindle cell and Sclerosing Rhabdomyosarcomas with Aggressive Clinical Outcomes. 𝘔𝘰𝘥𝘦𝘳𝘯 𝘗𝘢𝘵𝘩𝘰𝘭𝘰𝘨𝘺, 2016
[READ] [SUMMARY]

Chandrani P*, Prabhash K*, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Choughule A, Dutt A. Drug-sensitive FGFR3 mutations in lung adenocarcinoma. 𝘈𝘯𝘯𝘢𝘭𝘴 𝘰𝘧 𝘰𝘯𝘤𝘰𝘭𝘰𝘨𝘺, 2016
[READ] [SUMMARY]
  This work was featured here:
 [natureINDIA] [IndiaBioscience] [wellcomedbt] [Indian Express]

​

Chandrani P, Kulkarni V, Iyer P, Upadhyay P, Chaubal R, Das P, Mulherkar R, Singh R, Dutt A. , NGS Based Approach to Determine the Presence of HPV and Their Sites of Integration in Human Cancer Genome. 𝘉𝘳 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳. 2015 Apr.
[READ] [SUMMARY]
  This work was featured here: [Wellcome Trust DBT]

Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A,Prasannan P, Singh A, Iyer A, Singh A, Upadhyay P, Nair NK, Mishra PK, Dutt A. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. 𝘑 𝘉𝘪𝘰𝘴𝘤𝘪. 2015 Mar;40(1):91-111.
[READ] [SUMMARY]

Barreto SG, Barreto M, Chaubal R, Dutt A. The fight against cancer: Is it worthwhile? 𝘐𝘯𝘥𝘪𝘢𝘯 𝘑 𝘔𝘦𝘥 𝘗𝘢𝘦𝘥𝘪𝘢𝘵𝘳 𝘖𝘯𝘤𝘰𝘭. 2015 Apr-Jun;36(2):85-6. doi:10.4103/0971-5851.158833.
[READ] [SUMMARY]

Ramteke MP, Patel KJ, Godbole M,Maulik Vyas, Kunal Karve, Anuradha Choughule, Dutt A. CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons [version 2; referees: 2 approved, 1 approved with reservations]. 𝘍1000𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 2015, 4:160 (doi: 10.12688/f1000research.6663.1)
[READ] [SUMMARY]

Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram GV, Oak N, Singh A, Chaubal R, Ramteke M, Gupta S, Dutt A. Integrated genomics approach to identify biologically relevant alterations in fewer samples. 𝘉𝘔𝘊 𝘎𝘦𝘯𝘰𝘮𝘪𝘤𝘴. 2015 Nov 14;16(1):936. doi: 10.1186/s12864-015-2138-4.
[READ] [SUMMARY]

Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, Desai S, Chandrani P, Sundaram P, Utture S, Jambhekar N, Gupta S, Aich J*, Prabhash K*, Dutt A*. Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. 𝘉𝘳 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳. 2014 Nov 25;111(11) :2203-4.PubMed PMID: 25117816 *corresponding author
[READ] [SUMMARY]

Upadhyay P, Dwivedi R, Dutt A*. Application of NGS in Cancer Research. 𝘊𝘶𝘳𝘳𝘦𝘯𝘵 𝘚𝘤𝘪𝘦𝘯𝘤𝘦, 2014; 107 (5), 795 *corresponding author
[READ] [SUMMARY]

Barreto SG, Dutt A*, Adarsh Chaudhary. A Genetic Model for Gallbladder Carcinogenesis and its Dissemination. 𝘈𝘯𝘯𝘢𝘭𝘴 𝘰𝘧 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 2014 * corresponding author
[READ] [SUMMARY]
  a) A commentary published on this work:HBSN(HEPATOBILIARY SURGERY AND NUTRITION)
 [READ]

Chougule A, Prabhash K*, Noronha V, Joshi A, Thavamani A, Chandrani P, Upadhyay P, Utture S, Desai S, Jambhekar N, Dutt A*. Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity. 𝘗𝘓𝘰𝘚 𝘖𝘯𝘦. 2013 Oct 4;8(10):e76164. doi: 10.1371/journal.pone.0076164. * corresponding authors
[READ] [SUMMARY]

Choughule A, Noronha V, Joshi A, Desai S, Jambhekar N, Utture S, Thavamanni A, Prabhash K,Dutt A. Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients. 𝘐𝘯𝘥𝘪𝘢𝘯 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳. 2013 Apr-Jun;50(2):107-11. doi: 10.4103/0019-509X.117023.
[READ] [SUMMARY]

Noronha V, Prabhash K*, Thavamani A, Chougule A, Purandare N, Joshi A, Sharma R, Desai S, Jambekar N, Dutt A*, Mulherkar R. EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy. 𝘗𝘓𝘰𝘚 𝘖𝘯𝘦. 2013 Apr 19;8(4):e61561. doi: 10.1371/journal.pone.0061561. Print 2013. * corresponding authors
[READ] [SUMMARY]

Global Cancer Genomics Consortium.The Global Cancer Genomics Consortium’s Second  Annual Symposium: Genomics Medicine in Cancer Research. 𝘎𝘦𝘯𝘦𝘴 & 𝘊𝘢𝘯𝘤𝘦𝘳, May/June 2013;  vol. 4, 5-6: pp. 196-200., first published on April 17,2013
[READ]

Global Cancer Genomics Consortium. The Global Cancer Genomics Consortium: interfacing genomics and cancer medicine. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴. 2012 Aug 1;72(15):3720-4. Epub 2012 May 24
[READ]

Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, DuttA,Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, Kesari S, Meyerson M.Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴. 2011 Dec 15;71(24):7587-96.
[READ]

Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck SH, Peifer M, Simard JR, Lawrence MS, Onofrio RC, Salvesen HG, Seidel D, Zander T, Heuckmann JM, Soltermann A, Moch H, Koker M, Leenders F, Gabler F, Querings S, Ansen S, Brambilla E, Brambilla C, Lorimier P, Brustugun OT, Helland A, Petersen I, Clement JH, Groen H, Timens W, Sietsma H, Stoelben E, Wolf J, Beer DG, Tsao MS, Hanna M, Hatton C, Eck MJ, Janne PA, Johnson BE, Winckler W, Greulich H, Bass AJ, Cho J, Rauh D, Gray NS, Wong KK, Haura EB, Thomas RK, Meyerson M. Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺. June 2011 1:78-89 This article featured as cover page article of the issue.
[READ]

Dutt A*, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M*. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. 𝘗𝘓𝘰𝘚 𝘖𝘯𝘦. 2011;6(6):e20351. *corresponding authors
[READ] [SUMMARY]

Zhou W, Hur W, McDermott U,Dutt A, Xian W, Ficarro SB, Zhang J, Sharma SV, Brugge J, Meyerson M, Settleman J, Gray NS. A structure-guided approach to creating covalent FGFR inhibitors. 𝘊𝘩𝘦𝘮 𝘉𝘪𝘰𝘭. 2010 Mar 26;17(3):285-95.
[READ]

​

Book Chapter

• Pratik Chandrani, and Amit Dutt "Domain Specific Targeting of Cancer." Ed. Rakesh Kumar.  Nuclear Signaling Pathways and Targeting Transcription in Cancer. New York: Springer, 2014.  299-310. Cancer Drug Discovery and Development.
  [READ]

• Amit Dutt. Next Generation Sequencing and Cancer Biology-- an invited article in "Cutting Edge", May 2012, A Spinco Biotech Publication

Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A. , Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Jr UR, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. 𝘕𝘢𝘵 𝘎𝘦𝘯𝘦𝘵. 2009 Nov;41(11):1238-42.
[READ]

Ramos AH*, Dutt A. *, Mermel C, Perner S, Cho J, Lafargue CJ, Johnson LA, Stiedl AC, Tanaka KE, Bass AJ,Barretina J, Weir BA, Beroukhim R, Thomas RK, Minna JD, Chirieac LR, Lindeman NI, Giordano T, Beer DG, Wagner P, Wistuba II, Rubin MA,Meyerson M. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. 𝘊𝘢𝘯𝘤𝘦𝘳 𝘉𝘪𝘰𝘭 𝘛𝘩𝘦𝘳. 2009 Nov;8(21):2042-50. * co-first authors. This article featured as cover page article of the issue
[READ] [SUMMARY]

Dutt A. , Salvesen HB, Greulich H, Sellers WR, Beroukhim R, Meyerson M. Somatic mutations are present in all members of the AKT family in endometrial carcinoma. 𝘉𝘳 𝘑 𝘊𝘢𝘯𝘤𝘦𝘳. 2009 Oct 6;101(7):1218-9.
[READ] [SUMMARY]

Salvesen HB, Carter SL, Mannelqvist M, Dutt A. , Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, Wik E, Greulich H, B TH, Jonassen I, Thomas RK, Zander T, Garraway LA, Oyan AM, Sellers WR, Kalland KH, Meyerson M, Akslen LA, Beroukhim R. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. 𝘗𝘳𝘰𝘤 𝘕𝘢𝘵𝘭 𝘈𝘤𝘢𝘥 𝘚𝘤𝘪 𝘜 𝘚 𝘈. 2009 Mar 24;106(12):4834-9.
[READ]

Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A. , Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK. Somatic mutations affect key pathways in lung adenocarcinoma. 𝘕𝘢𝘵𝘶𝘳𝘦. 2008 Oct 23;455(7216):1069-75.
[READ]

Dutt A. , Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C, Nicoletti R, Winckler W, Grewal R, Hanna M, Wyhs N, Ziaugra L, Richter DJ, Trovik J, Engelsen IB, Stefansson IM, Fennell T, Cibulskis K, Zody MC, Akslen LA, Gabriel S, Wong KK, Sellers WR, Meyerson M, Greulich H. Drug-sensitive FGFR2 mutations in endometrial carcinoma. 𝘗𝘳𝘰𝘤 𝘕𝘢𝘵𝘭 𝘈𝘤𝘢𝘥 𝘚𝘤𝘪 𝘜 𝘚 𝘈. 2008 Jun 24;105(25):8713-7.
[READ]

Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A. , Emery C, Greulich H, Shah K, Sasaki H, Gazdar A, Minna J, Armstrong SA, Mellinghoff IK, Hodi FS, Dranoff G, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, Mertz K, Rubin MA, Moch H, Loda M, Catalona W, Fletcher J, Signoretti S, Kaye F, Anderson KC, Demetri GD, Dummer R, Wagner S, Herlyn M, Sellers WR, Meyerson M, Garraway LA. High-throughput oncogene mutation profiling in human cancer. 𝘕𝘢𝘵 𝘎𝘦𝘯𝘦𝘵. 2007 Mar;39(3):347-51.
[READ]

Dutt A. , Beroukhim R. Single nucleotide polymorphism array analysis of cancer. 𝘊𝘶𝘳𝘳 𝘖𝘱𝘪𝘯 𝘖𝘯𝘤𝘰𝘭. 2007 Jan;19(1):43-9. Review.
[READ] [SUMMARY]

Dutt A. , Wong KK. Mouse models of lung cancer. 𝘊𝘭𝘪𝘯 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴. 2006 Jul 15;12(14 Pt 2):4396s-4402s. Review.
[READ] [SUMMARY]

Murtaza I, Mushtaq D, Margoob MA, Dutt A. , Wani NA, Ahmad I, Bhat ML. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. 𝘞𝘰𝘳𝘭𝘥 𝘑 𝘎𝘢𝘴𝘵𝘳𝘰𝘦𝘯𝘵𝘦𝘳𝘰𝘭. 2006 Jul 7;12(25):4033-7.
[READ]

Murtaza I, Marra G, Schlapbach R, Patrignani A, K?nzli M, Wagner U, Sabates J, Dutt A. . A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. 𝘉𝘪𝘰𝘵𝘦𝘤𝘩𝘯𝘰𝘭 𝘈𝘱𝘱𝘭 𝘉𝘪𝘰𝘤𝘩𝘦𝘮. 2006 Jul;45(Pt 1):29-36.
[READ]

Murtaza I, Dutt A. , Mushtaq D, Ali A. Molecular cloning and genetic analysis of functional merB gene from indian isolates of Escherichia coli. 𝘊𝘶𝘳𝘳 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘭. 2005 Nov;51(5):297-302.
[READ]

Dutt A , Canevascini S, Froehli-Hoier E, Hajnal A. EGF signal propagation during C. elegans vulval development mediated by ROM-1 rhomboid. 𝘗𝘓𝘰𝘚 𝘉𝘪𝘰𝘭. 2004 Nov;2(11):e334.
[READ] [SUMMARY]

Murtaza I, Dutt A and Ali Arif 2002 Biomolecular engineering of organomercurial lyase in Escherichia coli. 𝘐𝘯𝘥𝘪𝘢𝘯 𝘑. 𝘉𝘪𝘰𝘵𝘦𝘤𝘩. 2002;1:117-120.
[READ]

Murtaza I, Dutt A , Ali A. Relationship between the persistence of mer operon sequences in Escherichia coli and their resistance to mercury. 𝘊𝘶𝘳𝘳 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘭. 2002 Mar;44(3):178-83.
[READ]

Murtaza I, Dutt A and Ali Arif. 2001 Inducible mercury operons in Broad Spectrum Escherichia coli Ind. J. 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘭. 2001; 41:169-17